Milestone Pharmaceuticals Inc.
MIST· Nasdaq
MISTMilestone Pharmaceuticals Inc.
Filed May 11, 2023 · 10-Q · 41 days after period end · 0001558370-23-009254
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Net Income | -$14.95M | -$14.01M | -$12.51M | -$16.34M |
| EPS Diluted | -$0.35 | -$0.33 | -$0.30 | -$0.67 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Pharmaceuticals Inc. · CIK 1408443 · Engraved from SEC EDGAR
ended Mar 31, 2023 · filed May 11, 2023 · 41 d after period end
